Phil Skolnick, Chief Scientific Officer at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 18,442 shares at $11.66 ($214K) on 2019-08-01, disclosed to the SEC on 2019-08-02.
Open-market sale of $214k OPNT by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.66 | 8,442 | $98K | 45.9% |
| 2 | $11.66 | 8,442 | $98K | 45.9% |
| 3 | $11.30 | 1,558 | $18K | 8.2% |
| Total | $11.63 avg | 18,442 | $214K | 100% |
| Filing → |
| OPNT | SELL | 2023-01-05 | $29K | — | Filing → |
| OPNT | SELL | 2022-07-15 | $7K | — | Filing → |
| OPNT | SELL | 2022-01-27 | $40K | — | Filing → |